Skip to main content
TipRanks
Go Ultimate75% OFF

Primo Chemicals Limited (PRIMO) AI Stock Analysis

1 Followers
IN:PRIMO

Primo Chemicals Limited

(NSE:PRIMO)

Select Model
Rating:59Neutral
Price Target:INR 22.00â–²(3.87% Upside)
Action:reiterated
Date:09/29/26

The overall score is constrained by weak operating performance and a high valuation. While the balance sheet is healthy and technical trends are strongly positive, flat revenue and declining operating margins present a significant risk to earnings sustainability. The lack of dividend yield and a P/E above 43 further reduce the score.

Positive Factors
Revenue GrowthThe sharp FY2026 revenue acceleration indicates materially stronger demand or business activity across Primo Chemicals’ industrial customer base. If maintained, this larger revenue base can improve operating leverage, support reinvestment, and strengthen the company’s position with downstream manufacturers over the next several quarters.
Negative Factors
Thin and Weaker Operating MarginsDespite strong revenue growth, operating margins deteriorated materially, indicating that higher costs or pricing pressure absorbed much of the top-line benefit. Persistently thin margins leave limited protection against further cost increases and make earnings more sensitive to changes in demand, pricing, and execution.

Primo Chemicals Limited (PRIMO) vs. iShares MSCI India ETF (INDA)

-30%-20%-10%0%10%20%30%IN:PRIMO-4.03%INDA-5.86%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 5.17B
Dividend Yield
―
Average Volume (3M)
38.46K
Price to Earnings (P/E)
32.6
Beta (1Y)
0.40
Revenue Growth
-2.70%
EPS Growth
-15.41%
Country
India
Employees
365
Sector
General
Sector Strength
55
Industry
Chemicals

Primo Chemicals Limited Business Overview & Revenue Model

Company Description

Headquartered in Chandigarh, India, Primo Chemicals Limited, established in 1975, is actively involved in the production and distribution of various chemical compounds across the country. The company's extensive product line encompasses industrial st...

Primo Chemicals Limited Financial Statement Overview

Summary

Mixed financial health. The balance sheet is stable with reduced leverage (D/E 0.32), and free cash flow grew 35%. However, revenue is flat, operating margins declined sharply, and the net income surge is driven by non-operating items, raising sustainability concerns.

Income Statement

38Negative

Balance Sheet

68Positive

Cash Flow

58Neutral
Financial statement breakdown
BreakdownTTMMar 2025Mar 2024
Income Statement
Total Revenue2.90B5.62B5.56B
Gross Profit1.07B1.05B995.93M
EBITDA481.37M682.87M833.64M
Net Income37.51M153.71M35.60M
Balance Sheet
Total Assets7.34B6.92B7.41B
Cash, Cash Equivalents and Short-Term Investments138.79M107.08M82.46M
Total Debt1.62B1.31B1.69B
Total Liabilities3.35B2.86B3.50B
Stockholders Equity3.99B4.06B3.91B
Cash Flow
Free Cash Flow164.50M327.29M242.82M
Operating Cash Flow504.21M587.45M644.34M
Investing Cash Flow-303.76M-194.76M-446.55M
Financing Cash Flow-194.10M-384.17M-90.29M

Primo Chemicals Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price21.18

Price Trends

50DMA23.28Negative
100DMA23.36Negative
200DMA22.57Negative

Market Momentum

MACD-0.75Positive
RSI40.23Neutral
STOCH45.00Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:PRIMO, the sentiment is Negative. The current price of 21.18 is below the 20-day moving average (MA) of 22.70, below the 50-day MA of 23.28, and below the 200-day MA of 22.57, indicating a bearish trend. The MACD of -0.75 indicates Positive momentum. The RSI at 40.23 is Neutral, neither overbought nor oversold. The STOCH value of 45.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:PRIMO.

Primo Chemicals Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:PRIMO against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:INDOAMININ:INDOAMIN76OutperformINR 8.49B10.50―0.43%13.23%22.22%
IN:VALIANTORGIN:VALIANTORG63NeutralINR 10.18B15.45――21.32%175.87%
IN:PRIMOIN:PRIMO59NeutralINR 5.13B32.64――-2.70%-15.41%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:DMCCIN:DMCC53NeutralINR 6.18B16.46―1.00%72.14%34.49%
IN:UNIENTERIN:UNIENTER51NeutralINR 6.63B34.44―3.65%-68.82%1.74%
IN:DIAMINESQIN:DIAMINESQ43NeutralINR 2.34B-28.20―0.43%-27.77%-61.55%

* General Sector Average

Performance Comparison

-25%0%25%50%IN:PRIMOIN:DIAMINESQIN:DMCCIN:INDOAMININ:UNIENTERIN:VALIANTORGDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:PRIMO and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:PRIMOPrimo Chemicals Limited21.18-1.43-6.32%
IN:DIAMINESQDiamines & Chemicals Ltd.232.70-51.30-18.06%
IN:DMCCDMCC Speciality Chemicals Limited247.70-31.84-11.39%
IN:INDOAMINIndo Amines Limited117.00-14.17-10.80%
IN:UNIENTERUniphos Enterprises Limited95.35-54.14-36.21%
IN:VALIANTORGValiant Organics Limited363.3077.4527.09%

Primo Chemicals Limited Corporate Events

Primo Chemicals Publishes Unaudited Financial Results Advertisements

Nov 3, 2026

Primo Chemicals Limited operates in the chemicals industry; the release does not specify its primary products, services, or market focus.The company notified the exchanges that advertisements for its unaudited standalone and consolidated financial re...

Primo Chemicals Moves to Merge Flow Tech Subsidiary for Streamlined Growth

Sep 25, 2026

Primo Chemicals Limited’s board has approved a draft scheme of amalgamation to merge its wholly owned subsidiary, Flow Tech Chemicals Private Limited, into the parent company, effective from October 1, 2026, subject to corporate, regulatory and Natio...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 29, 2026